Clinical trial
Combination of Efavirenz and Truvada - COMET Study
NCT00224458 · Gilead Sciences, Industry · Completed
Key facts
| NCT number | NCT00224458 |
|---|---|
| Title | Combination of Efavirenz and Truvada - COMET Study |
| Official title | Combination of Efavirenz & Truvada (COMET Study): Phase 4 Evaluation of Switching Twice Daily Combivir to Once-Daily Regimen Co-Formulated Truvada in Virologically Suppressed HIV Infected Patients Taking Efavirenz. |
| Lead sponsor | Gilead Sciences, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Truvada, efavirenz |
| Enrollment | 400 |
| Start date | Sep 1, 2004 |
| Completion | Feb 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Apr 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: